1. Home
  2. AMPH vs EDN Comparison

AMPH vs EDN Comparison

Compare AMPH & EDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • EDN
  • Stock Information
  • Founded
  • AMPH 1996
  • EDN 1992
  • Country
  • AMPH United States
  • EDN Argentina
  • Employees
  • AMPH N/A
  • EDN N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • EDN Electric Utilities: Central
  • Sector
  • AMPH Health Care
  • EDN Utilities
  • Exchange
  • AMPH Nasdaq
  • EDN Nasdaq
  • Market Cap
  • AMPH 1.1B
  • EDN 1.2B
  • IPO Year
  • AMPH 2014
  • EDN 2007
  • Fundamental
  • Price
  • AMPH $21.70
  • EDN $25.30
  • Analyst Decision
  • AMPH Hold
  • EDN
  • Analyst Count
  • AMPH 5
  • EDN 0
  • Target Price
  • AMPH $38.00
  • EDN N/A
  • AVG Volume (30 Days)
  • AMPH 501.2K
  • EDN 89.2K
  • Earning Date
  • AMPH 08-06-2025
  • EDN 08-05-2025
  • Dividend Yield
  • AMPH N/A
  • EDN N/A
  • EPS Growth
  • AMPH N/A
  • EDN N/A
  • EPS
  • AMPH 2.77
  • EDN 0.21
  • Revenue
  • AMPH $730,659,000.00
  • EDN $2,097,707,542.00
  • Revenue This Year
  • AMPH $0.67
  • EDN $51.74
  • Revenue Next Year
  • AMPH $5.18
  • EDN N/A
  • P/E Ratio
  • AMPH $7.83
  • EDN $6.09
  • Revenue Growth
  • AMPH 8.05
  • EDN 37.57
  • 52 Week Low
  • AMPH $21.48
  • EDN $13.78
  • 52 Week High
  • AMPH $53.96
  • EDN $51.69
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 28.01
  • EDN 37.52
  • Support Level
  • AMPH $22.81
  • EDN $24.73
  • Resistance Level
  • AMPH $23.77
  • EDN $28.46
  • Average True Range (ATR)
  • AMPH 0.76
  • EDN 1.42
  • MACD
  • AMPH -0.20
  • EDN 0.03
  • Stochastic Oscillator
  • AMPH 9.27
  • EDN 15.28

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About EDN Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor)

Empresa Distribuidora y Comercializadora Norte SA is engaged in the distribution and sale of electricity. The firm's concession area covers the northern portion of the city of Buenos Aires mainly to residential, commercial, industrial, and public service.

Share on Social Networks: